Literature DB >> 2509809

Disorders of mitochondrial beta-oxidation: prenatal and early postnatal diagnosis and their relevance to Reye's syndrome and sudden infant death.

R J Pollitt1.   

Abstract

There are still many problems with the diagnosis and classification of inherited disorders of mitochondrial beta-oxidation. At present only the acyl-CoA dehydrogenase step of the beta-oxidation spiral has been explored in any detail and a large number of patients have disorders that cannot be properly characterized. beta-Oxidation defects may present in a wide variety of ways, the most dramatic being acute encephalopathy with hepatic involvement (atypical Reye's syndrome) or 'sudden' death. Investigations may include urinary and plasma organic acids, metabolic stress tests and assays of overall metabolic pathways or of specific enzymes in cultured fibroblasts, lymphocytes, or other material. Early postnatal diagnosis presents particular difficulties but in medium-chain acyl-CoA dehydrogenase deficiency the diagnosis may be apparent from careful examination of urine. There is as yet little general experience in prenatal diagnosis of this group of disorders except for glutaric aciduria type II. Single prenatal diagnoses of medium-chain acyl-CoA dehydrogenase deficiency and of an incompletely characterized defect of medium-chain fatty acid oxidation have been performed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509809     DOI: 10.1007/bf01799297

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  40 in total

1.  Generalised dicarboxylic aciduria: a common finding in neonates.

Authors:  M Downing; P Rose; M J Bennett; N J Manning; R J Pollitt
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Inherited defects of mitochondrial fatty acid oxidation.

Authors:  D M Turnbull; I M Shepherd; A Aynsley-Green
Journal:  Biochem Soc Trans       Date:  1988-06       Impact factor: 5.407

3.  The use of phenylpropionic acid as a loading test for medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  J W Seakins; G Rumsby
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

4.  Screening siblings for inborn errors of fatty acid metabolism in families with a history of sudden infant death.

Authors:  M J Bennett; S Variend; R J Pollitt
Journal:  Lancet       Date:  1986 Dec 20-27       Impact factor: 79.321

5.  A simple screening test for medium-chain acyl CoA dehydrogenase deficiency.

Authors:  G Rumsby; J W Seakins; J V Leonard
Journal:  Lancet       Date:  1986-08-23       Impact factor: 79.321

6.  Medium-chain and long-chain acyl CoA dehydrogenase deficiency: clinical, pathologic and ultrastructural differentiation from Reye's syndrome.

Authors:  W R Treem; C A Witzleben; D A Piccoli; C A Stanley; D E Hale; P M Coates; J B Watkins
Journal:  Hepatology       Date:  1986 Nov-Dec       Impact factor: 17.425

7.  3-Hydroxyoctanoic aciduria: identification of a new organic acid in the urine of a patient with non-ketotic hypoglycemia.

Authors:  R I Kelley; D H Morton
Journal:  Clin Chim Acta       Date:  1988-06-30       Impact factor: 3.786

8.  Multiple acyl-Co A dehydrogenation deficiency (MADD) in a boy with nonketotic hypoglycemia, hepatomegaly, muscle hypotonia and cardiomyopathy. Detection of N-isovalerylglutamic acid and its monoamide.

Authors:  A Niederwieser; B Steinmann; U Exner; F Neuheiser; U Redweik; M Wang; S Rampini; U Wendel
Journal:  Helv Paediatr Acta       Date:  1983-03

9.  Glutaric aciduria type II: biochemical investigation and treatment of a child diagnosed prenatally.

Authors:  M J Bennett; D A Curnock; P C Engel; L Shaw; R G Gray; D Hull; A D Patrick; R J Pollitt
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

10.  Recurrent hypoglycemia associated with glutaric aciduria type II in an adult.

Authors:  G Dusheiko; M C Kew; B I Joffe; J R Lewin; S Mantagos; K Tanaka
Journal:  N Engl J Med       Date:  1979-12-27       Impact factor: 91.245

View more
  7 in total

1.  Octanoate and palmitate beta-oxidation in human leukocytes: implications for the rapid diagnosis of fatty acid beta-oxidation disorders.

Authors:  R J Wanders; L Ijlst; E van Elk; J B de Klerk; H Przyrembel
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  The long-chain 3-hydroxyacyl-CoA dehydrogenase of human liver mitochondria.

Authors:  K Carpenter; B Middleton; R J Pollitt
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts.

Authors:  N J Manning; S E Olpin; R J Pollitt; J Webley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 4.  Immunology of hepatic diseases during pregnancy.

Authors:  Lars Bremer; Christoph Schramm; Gisa Tiegs
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

5.  Prenatal diagnosis of a defect in medium-chain fatty acid oxidation.

Authors:  R J Pollitt; N J Manning; S E Olpin; I D Young
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

6.  Medium-chain acyl CoA dehydrogenase deficiency: Its relationship to SIDS and the impact on genetic counseling.

Authors:  A McConkie-Rosell; A K Iafolla
Journal:  J Genet Couns       Date:  1993-03       Impact factor: 2.537

7.  Thioredoxin interacting protein protects mice from fasting induced liver steatosis by activating ER stress and its downstream signaling pathways.

Authors:  Hiroyuki Miyahara; Kosei Hasegawa; Masato Yashiro; Toshiaki Ohara; Masayoshi Fujisawa; Teizo Yoshimura; Akihiro Matsukawa; Hirokazu Tsukahara
Journal:  Sci Rep       Date:  2022-03-21       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.